Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN /Smn splicing

Human Molecular Genetics

Volumn 19, Issue 11, 2010, Pages 2154-2167

  Mende, Ylva ^a   Jakubik, Miriam ^a   Riessland, Markus ^a   Schoenen, Frank ^a   Roßbach, Kristina ^a   Kleinridders, André ^a,b   Köhler, Christoph ^a   Buch, Thorsten ^a   Wirth, Brunhilde ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CRE RECOMBINASE; SPLICING FACTOR ARGININE SERINE RICH 10; SURVIVAL MOTOR NEURON PROTEIN; UNCLASSIFIED DRUG; INTEGRASE; NUCLEAR PROTEIN; PRIMER DNA; RNA BINDING PROTEIN; SMN1 PROTEIN, MOUSE; SURVIVAL MOTOR NEURON PROTEIN 1; TRA2B PROTEIN, MOUSE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; FIBROBLAST CULTURE; GENE DELETION; GENE EXPRESSION REGULATION; HOMOZYGOTE; LOXP SITE; MOTONEURON; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RNA SPLICING; SPINAL CORD; ANIMAL; CELL CULTURE; EXON; FIBROBLAST; GENETIC TRANSDUCTION; GENETICS; GENOTYPE; IMMUNOHISTOCHEMISTRY; METABOLISM; TRANSGENIC MOUSE;

MURINAE; MUS;

ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; DNA PRIMERS; EMBRYO LOSS; EXONS; FIBROBLASTS; GENE DELETION; GENOTYPE; IMMUNOHISTOCHEMISTRY; INTEGRASES; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; RNA-BINDING PROTEINS; SURVIVAL OF MOTOR NEURON 1 PROTEIN; TRANSDUCTION, GENETIC;

EID: 77953519937     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq094     Document Type: Article

References (65)

1. Tacke, R., Tohyama, M., Ogawa, S. and Manley, J.L. (1998) Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell, 93, 139-148.
2. Beil, B., Screaton, G. and Stamm, S. (1997) Molecular cloning of htra2-beta-1 and htra2-beta-2, two human homologs of tra-2 generated by alternative splicing. DNA Cell. Biol., 16, 679-690.
3. Kiryu-Seo, S., Matsuo, N., Wanaka, A., Ogawa, S., Tohyama, M. and Kiyama, H. (1998) A sequence-specific splicing activator, tra2beta, is up-regulated in response to nerve injury. Brain Res. Mol. Brain Res., 62, 220-223.
4. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M. and Stamm, S. (1999) Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci., 11, 788-802.
5. Tsukamoto, Y., Matsuo, N., Ozawa, K., Hori, O., Higashi, T., Nishizaki, J., Tohnai, N., Nagata, I., Kawano, K., Yutani, C. et al. (2001) Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation. Am. J. Pathol., 158, 1685-1694.
6. Watermann, D.O., Tang, Y., Zur Hausen, A., Jager, M., Stamm, S. and Stickeler, E. (2006) Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res., 66, 4774-4780.
7. Segade, F., Hurle, B., Claudio, E., Ramos, S. and Lazo, P.S. (1996) Molecular cloning of a mouse homologue for the Drosophila splicing regulator Tra2. FEBS Lett., 387, 152-156.
8. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T.A. and Soreq, H. (2005) Function of alternative splicing. Gene, 344, 1-20.
9. Stoilov, P., Daoud, R., Nayler, O. and Stamm, S. (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum. Mol. Genet., 13, 509-524.
10. Chen, X., Huang, J., Li, J., Han, Y., Wu, K. and Xu, P. (2004) Tra2betal regulates P19 neuronal differentiation and the splicing of FGF-2R and GluR-B minigenes. Cell Biol. Int., 28, 791-799.
11. Stamm, S., Casper, D., Hanson, V. and Helfman, D.M. (1999) Regulation of the neuron-specific exon of clathrin light chain B. Brain Res. Mol. Brain Res., 64, 108-118.
12. Shukla, S. and Fisher, S.A. (2008) Tra2beta as a novel mediator of vascular smooth muscle diversification. Circ. Res., 103, 485-492.
13. Venables, J.P., Bourgeois, C.F., Dalgliesh, C., Kister, L., Stevenin, J. and Elliott, D.J. (2005) Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon. Hum. Mol. Genet., 14, 2289-2303.
14. Venables, J.P., Elliott, D.J., Makarova, O.V., Makarov, E.M., Cooke, H.J. and Eperon, I.C. (2000) RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. Hum. Mol. Genet., 9, 685-694.
15. Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R. and Wu, J.Y. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem., 278, 18997-19007.
16. Kondo, S., Yamamoto, N., Murakami, T., Okumura, M., Mayeda, A. and Imaizumi, K. (2004) Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA. Genes Cells, 9, 121-130.
17. Nissim-Rafinia, M., Aviram, M., Randell, S.H., Shushi, L., Ozeri, E., Chiba-Falek, O., Eidelman, O., Pollard, H.B., Yankaskas, J.R. and Kerem, B. (2004) Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep, 5, 1071-1077
18. Kwabi-Addo, B., Ropiquet, F., Giri, D. and Ittmann, M. (2001) Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate, 46, 163-172.
19. Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J. and Wirth, B. (2000) Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl Acad. Sci. USA, 97, 9618-9623.
20. Hofmann, Y. and Wirth, B. (2002) hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum. Mol. Genet., 11, 2037-2049.
21. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
22. Wirth, B. (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat., 15, 228-237.
23. Burglen, L., Lefebvre, S., Clermont, O., Burlet, P., Viollet, L., Cruaud, C., Munnich, A. and Melki, J. (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics, 32, 479-482.
24. Feldkotter, M., Schwarzer, V., Wirth, R., Wienker, T.F. and Wirth, B. (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet., 70, 358-368
25. Burghes, A.H. (1997) When is a deletion not a deletion? When it is converted. Am. J. Hum. Genet., 61, 9-15.
26. Wirth, B., Brichta, L., Schrank, B., Lochmuller, H., Blick, S., Baasner, A. and Heller, R. (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum. Genet., 119, 422-428.
27. Lorson, C.L., Hahnen, E., Androphy, E.J. and Wirth, B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA, 96, 6307-6311
28. Cartegni, L. and Krainer, A.R. (2002) Disruption of an SF2/ ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet., 30, 377-384.
29. Kashima, T. and Manley, J.L. (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet., 34, 460-463
30. Young, P.J., DiDonato, C.J., Hu, D., Kothary, R., Androphy, E.J. and Lorson, C.L. (2002) SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. Hum. Mol. Genet., 11, 577-587.
31. Bose, J.K., Wang, I.F., Hung, L., Tarn, W.Y. and Shen, C.K. (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J. Biol. Chem., 283, 28852-28859.
32. Brichta, L., Hofmann, Y., Hahnen, E., Siebzehnrubl, F.A., Raschke, H., Blumcke, I., Eyupoglu, I.Y. and Wirth, B. (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum. Mol. Genet., 12, 2481-2489.
33. Brichta, L., Holker, I., Haug, K., Klockgether, T. and Wirth, B. (2006) In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann. Neurol., 59, 970-975.
34. Riessland, M., Brichta, L., Hahnen, E. and Wirth, B. (2006) The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum. Genet., 120, 101-110.
35. Wirth, B., Brichta, L. and Hahnen, E. (2006) Spinal muscular atrophy: from gene to therapy. Semin. Pediatr. Neurol., 13, 121-131.
36. Sumner, C.J., Huynh, T.N., Markowitz, J.A., Perhac, J.S., Hill, B., Coovert, D.D., Schussler, K., Chen, X., Jarecki, J., Burghes, A.H. et al. (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann. Neurol., 54, 647-654.
37. Riessland, M., Ackermann, B., Forster, A., Jakubik, M., Hauke, J., Garbes, L., Fritzsche, I., Mende, Y., Blumcke, I., Hahnen, E. et al. (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum. Mol. Genet., doi:10.1093/hmg/ddq023, advance access published February 8, 2010.
38. Baker, B.S. (1989) Sex in flies: the splice of life. Nature, 340, 521-524
39. Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A.F. and Dymecki, S.M. (2000) High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet., 25, 139-140.
40. Schwenk, F., Baron, U. and Rajewsky, K. (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res., 23, 5080-5081.
41. Peitz, M., Pfannkuche, K., Rajewsky, K. and Edenhofer, F. (2002) Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA, 99, 4489-4494.
42. DiDonato, C.J., Brun, T. and Simard, L.R. (1999) Complete nucleotide sequence, genomic organization, and promoter analysis of the murine survival motor neuron gene (Smn). Mamm. Genome, 10, 638-641.
43. DiDonato, C.J., Chen, X.N., Noya, D., Korenberg, J.R., Nadeau, J.H. and Simard, L.R. (1997) Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res., 7, 339-352.
44. Arber, S., Han, B., Mendelsohn, M., Smith, M., Jessell, T.M. and Sockanathan, S. (1999) Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron, 23, 659-674.
45. Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H. and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet., 24, 66-70.
46. Monani, U.R., Coovert, D.D. and Burghes, A.H. (2000) Animal models of spinal muscular atrophy. Hum. Mol. Genet., 9, 2451-2457.
47. Wirth, B., Brichta, L. and Hahnen, E. (2006) Spinal muscular atrophy and therapeutic prospects. Prog. Mol. Subcell. Biol., 44, 109-132
48. Garbes, L., Riessland, M., Holker, I., Heller, R., Hauke, J., Trankle, C., Coras, R., Blumcke, I., Hahnen, E. and Wirth, B. (2009) LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum. Mol. Genet., 18, 3645-3658.
49. McLaren, A. (1976) Growth from Fertilization to Birth in the Mouse, Elsevier, New York, NY.
50. Jumaa, H., Wei, G. and Nielsen, P.J. (1999) Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr. Biol., 9, 899-902.
51. Xu, X., Yang, D., Ding, J.H., Wang, W., Chu, P.H., Dalton, N.D., Wang, H.Y., Bermingham, J.R. Jr, Ye, Z., Liu, F. et al. (2005) ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell, 120, 59-72.
52. Wang, H.Y., Xu, X., Ding, J.H., Bermingham, J.R. Jr and Fu, X.D. (2001) SC35 plays a role in T cell development and alternative splicing of CD45. Mol. Cell, 7, 331-342.
53. Williamson, D.J., Banik-Maiti, S., DeGregori, J. and Ruley, H.E. (2000) hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. Mol. Cell. Biol., 20, 4094-4105.
54. Lin, S., Xiao, R., Sun, P., Xu, X. and Fu, X.D. (2005) Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation. Mol. Cell, 20, 413-425.
55. DiDonato, C.J., Lorson, C.L., De Repentigny, Y., Simard, L., Chartrand, C., Androphy, E.J. and Kothary, R. (2001) Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum. Mol. Genet., 10, 2727-2736.
56. Lorson, C.L. and Androphy, E.J. (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet., 9, 259-265.
57. Skordis, L.A., Dunckley, M.G., Yue, B., Eperon, I.C. and Muntoni, F. (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc. Natl Acad. Sci. USA, 100, 4114-4119.
58. Cartegni, L. and Krainer, A.R. (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol., 10, 120-125.
59. Meyer, K., Marquis, J., Trub, J., Nlend Nlend, R., Verp, S., Ruepp, M.D., Imboden, H., Barde, I., Trono, D. and Schumperli, D. (2009) Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation. Hum. Mol. Genet., 18, 546-555.
60. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossol, W., Prior, T.W. et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(2/2) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
61. Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F.T., von Kleist-Retzow, J.C., Waisman, A., Westermann, B. and Langer, T. (2008) Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev., 22, 476-488.
62. Eggan, K., Rode, A., Jentsch, I., Samuel, C., Hennek, T., Tintrup, H., Zevnik, B., Erwin, J., Loring, J., Jackson-Grusby, L. et al. (2002) Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation. Nat. Biotechnol., 20, 455-459.
63. Kuhn, R. and Torres, R.M. (2002) Cre/loxP recombination system and gene targeting. Methods Mol. Biol., 180, 175-204.
64. Laird, P.W., Zijderveld, A., Linders, K., Rudnicki, M.A., Jaenisch, R. and Berns, A. (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res., 19, 4293.
65. Nagy, A., Gertsenstein, M., Vintersten, K. and Behringer, R. (2003) Manipulating the Mouse Embryo, A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.